Adam Vogel
Stock Analyst at Craig-Hallum
(2.43)
# 3,048
Out of 5,096 analysts
35
Total ratings
41.2%
Success rate
2.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Adam Vogel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACRS Aclaris Therapeutics | Reiterated: Buy | $10 → $9 | $3.80 | +136.84% | 7 | Oct 28, 2026 | |
| TSX: MSCL Satellos Bioscience Inc. | Initiated Coverage: Buy | $33.54 | $9.05 | +270.59% | 1 | Oct 8, 2026 | |
| ATHE Alterity Therapeutics | Rated: Buy | $12 → $15 | $2.09 | +617.70% | 2 | Oct 5, 2026 | |
| IMNM Immunome | Reiterated: Buy | $36 | $19.59 | +83.77% | 9 | Aug 12, 2026 | |
| LBRX LB Pharmaceuticals | Reiterated: Buy | $36 → $45 | $39.04 | +15.27% | 5 | Aug 12, 2026 | |
| PEPG PepGen | Reiterated: Buy | $11 | $2.35 | +368.09% | 2 | Aug 6, 2026 | |
| DSGN Design Therapeutics | Reiterated: Buy | $22 | $10.15 | +116.75% | 5 | Aug 4, 2026 | |
| MPLT MapLight Therapeutics | Reiterated: Buy | $40 → $25 | $6.78 | +268.73% | 3 | Jul 28, 2026 | |
| HIT Health In Tech | Reiterated: Buy | n/a | $0.5848 | - | 1 | Apr 10, 2026 |
Aclaris Therapeutics
Oct 28, 2026
Reiterated: Buy
Price Target: $10 → $9
Current: $3.80
Upside: +136.84%
Satellos Bioscience Inc.
Oct 8, 2026
Initiated Coverage: Buy
Price Target: $33.54
Current: $9.05
Upside: +270.59%
Alterity Therapeutics
Oct 5, 2026
Rated: Buy
Price Target: $12 → $15
Current: $2.09
Upside: +617.70%
Immunome
Aug 12, 2026
Reiterated: Buy
Price Target: $36
Current: $19.59
Upside: +83.77%
LB Pharmaceuticals
Aug 12, 2026
Reiterated: Buy
Price Target: $36 → $45
Current: $39.04
Upside: +15.27%
PepGen
Aug 6, 2026
Reiterated: Buy
Price Target: $11
Current: $2.35
Upside: +368.09%
Design Therapeutics
Aug 4, 2026
Reiterated: Buy
Price Target: $22
Current: $10.15
Upside: +116.75%
MapLight Therapeutics
Jul 28, 2026
Reiterated: Buy
Price Target: $40 → $25
Current: $6.78
Upside: +268.73%
Health In Tech
Apr 10, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.5848
Upside: -